BIO Executive Vice President for Health Policy Dan Durham released statement regarding White House announcement of actions to accelerate the Precision Medicine Initiative. "The data and discoveries resulting from this Initiative may play a critical role in enabling biopharmaceutical companies to develop treatments for patients before or early on in their disease progression, and with therapeutics that are far more effective and focused on the specific characteristics of their particular disease."